CD133 as a target for colon cancer

Author： Catalano Veronica   Di Franco Simone   Iovino Flora   Dieli Francesco   Stassi Giorgio   Todaro Matilde  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.3, 2012-03, pp. : 259-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting CD133 antigen in cancer

By Ferrandina Gabriella   Petrillo Marco   Bonanno Giuseppina   Scambia Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 823-837

Informa Healthcare

Access to resources Recommend Favorite

CD133++ cells as a therapeutic target for kidney diseases

By Bussolati Benedetta   Collino Federica   Camussi Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 157-165

Informa Healthcare

Access to resources Recommend Favorite

CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

By Borghese Federica   Clanchy Felix IL  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 237-251

Informa Healthcare

Access to resources Recommend Favorite

CD44: a validated target for improved delivery of cancer therapeutics

By Ghosh Sukhen C   Neslihan Alpay Sultan   Klostergaard Jim  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 635-650

Informa Healthcare

Access to resources Recommend Favorite

Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite